Experts discuss the patient case of Janet, a 58-year-old with her 2 positive metastatic breast cancer, and after 14 months on ...

Subcutaneous administration of trastuzumab and pertuzumab significantly ... and shortened the workflow for the pharmacy. “Time toxicity doesn’t get talked about enough,” Adrienne G.

Cardiac Toxicity of Trastuzumab. Left ventricular ejection fraction evaluation was performed every 2 cycles. In case of LVEF < 40%, trastuzumab was permanently discontinued. If the treatment ...

and skin infections. The serum concentration of the active metabolites of Trastuzumab emtansine can be increased when Trastuzumab emtansine is used in combination with Clarithromycin.

with clinical activity and mild toxicity. The promising results should be further explored in Phase III randomized clinical trials. The combination of gemcitabine plus trastuzumab in patients with ...

The low toxicity of [vic-]trastuzumab duocarmazine and its action as a drug that damages DNA gives it potential as part of a combination therapy, for example, with PARP inhibitors, which stop the ...

Subcutaneous administration of trastuzumab and pertuzumab significantly shortened the time patients with stage I HER2-positive breast cancer spent getting treatment compared with IV delivery ...